New evidence reported by researchers at Roswell Park Cancer Institute lends support to the hypothesis that the SSeCKS/AKAP12 gene is a key inhibitor of prostate cancer metastasis. The data are some of the first to demonstrate this dynamic in transgenic animal models, with promising implications for development of targeted therapies for prostate cancer and perhaps for other solid-tumor cancers. Read more here.
Study mentioned: Ko HK, et al. A transgenic mouse model for early prostate metastasis to lymph nodes. Cancer Res. 2014 Feb 1;74(3):945-53. PMID: 24492704
No comments:
Post a Comment